ebook img

Employee Assistance Program: Prescription Drug Toolkit and Fact Sheets PDF

2021·1.7 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Employee Assistance Program: Prescription Drug Toolkit and Fact Sheets

EMPLOYEE ASSISTANCE PROGRAM Prescription Drug Toolkit and Fact Sheets 1 Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets Acknowledgments This toolkit was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) under contract number S830700012I42001 with SAMHSA, U.S. Department of Health and Human Services (HHS). Deborah Galvin, Ph.D., served as the Government Project Officer. Disclaimer The views, opinions, and content of this publication are those of the author and do not necessarily reflect the views, opinions, or policies of SAMHSA. Public Domain Notice All material appearing in this report is in the public domain and may be reproduced or copied without permission from SAMHSA. Citation of the source is appreciated. However, this publication may not be reproduced or distributed for a fee without the specific, written authorization of the Office of Communications, SAMHSA. Electronic Access This publication may be downloaded at http://store.samhsa.gov. Recommended Citation Substance Abuse and Mental Health Services Administration, Employee Assistance Program Prescription Drug Toolkit and Fact Sheets. Publication No. PEP20-03-02-001. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2021. Nondiscrimination Notice SAMHSA complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. SAMHSA cumple con las leyes federales de derechos civiles aplicables y no discrimina por motivos de raza, color, nacionalidad, edad, discapacidad o sexo. Originating Office Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Publication No. PEP20-03-02-001. Released 2021. Contents Executive Summary .............................................................................................. i The Scope of Employee Prescription Drug Misuse ..............................................1 Prescription Drugs in Combination with Illicit Drugs and Alcohol ..........................2 Workplace Awareness and Prevention .................................................................3 Employee Programs and Services for Prescription Drug Misuse and Addiction ...8 Screening for Prescription Drug Misuse ............................................................. 11 Fitness-for-Duty ................................................................................................. 16 Alternatives to Prescription Drugs ...................................................................... 18 Pain Relief Strategies.........................................................................................20 Return to Work ...................................................................................................22 Relapse Prevention ............................................................................................ 24 Employee Educational Materials ........................................................................ 26 Executive Summary The Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides guidance related to counseling, referrals, and follow-up services that EAPs can offer employees whose substance misuse has affected their workplace environment. The Toolkit also shares insight for employers about preventing substance misuse and maintaining professional standards. These materials describe the ways in which EAPs provide alternatives to prescription drugs, workplace drug misuse and relapse prevention, information on the dangers of combined drug use, screenings, and evaluations before returning to work. The Scope of Employee Prescription Drug Misuse Prescription drug misuse, including non-medical use, is a serious problem for employees and workplaces in the United States. Employee Assistance Programs (EAPs) can connect employees with confidential access to treatment and help them find providers. EAPs also can help monitor employees’ progress after they begin treatment to support recovery and successful job performance. In 2019, 5.7 percent of full-time employed 18- to 25- The rate of opioid-related emergency department visits year-olds reported misuse of pain relievers in the past more than doubled from 2008 to 2017.6 year.1 The negative associations often accompanying substance misuse may PRESCRIPTION DRUG MISUSE: Taking a medication in a manner or dose prevent employees from getting the help other than prescribed; taking someone they need to recover. else’s prescription, even if for legitimate EAPs can help employees by connecting them with medical complaints such as pain; or confidential access to treatment and helping them find taking a medication to feel euphoria.2 providers. References The problem is most prevalent among 1 Substance Abuse and Mental Health Services Administration (SAMHSA). 18- to 25-year-olds. (2020). Results from the 2019 National Survey on Drug Use and Health: Detailed Tables. Retrieved from https://www.samhsa.gov/data/report/2019- In 2019, 42 percent of full-time employed 18- to 25-year- nsduh-detailed-tables olds reported illicit drug use in the past year.3 Employees 2 National Institute on Drug Abuse. (2018). Misuse of Prescription Drugs. in all age groups report some misuse of prescription Research Report Series. Retrieved from https://www.drugabuse.gov/publications/misuse-prescription-drugs/overview drugs. 3 Substance Abuse and Mental Health Services Administration (SAMHSA). (2020). Results from the 2019 National Survey on Drug Use and Health: Opioid pain relievers are the most Detailed Tables. Retrieved from https://www.samhsa.gov/data/report/2019- nsduh-detailed-tables commonly misused prescription drugs. 4 Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from According to the 2019 National Survey on Drug Use and the 2019 National Survey on Drug Use and Health (HHS Publication No. Health (NSDUH) data, approximately 9.7 million people PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services in 2019 misused prescription pain relievers in the past Administration. Retrieved from https://www.samhsa.gov/data/ year.4 5 Hedegaard, H., Warner, M., & Miniño, A. M. (2017). Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, no 294. Hyattsville, MD: In 2017, opioids were involved in National Center for Health Statistics. Retrieved from https://www.cdc.gov/drugoverdose/data/statedeaths.html 47,600 overdose deaths. 6 Healthcare Cost and Utilization Project (HCUP). (2017). HCUP Fast Stats. Agency for Healthcare Research and Quality, Rockville, MD. Retrieved from From 2016 to 2017, there were significant increases in https://www.hcup-us.ahrq.gov/faststats/OpioidUseServlet? location1=US&characteristic1=01&setting1=ED&location2 opioid overdose deaths in the Northeast, Midwest, and =&characteristic2=01&setting2=ED&expansionInfoState South census regions.5 =hide&dataTablesState=hide&definitionsState=hide&exportState=hide 1 Prescription Drugs in Combination with Illicit Drugs and Alcohol Employees engaging in the non-medical use of prescription drugs may be doing so in combination with alcohol or other substances. It is important for Employee Assistance Program (EAP) providers to screen for the use of all substances including medical and prescription drug misuse. It is important for EAP providers to understand how • Focusing on young adults ages 18 to 29 years old prescription drugs are used in combination with illicit engaged in urban nightlife, a study found that nearly 25 drugs or alcohol, as well as the extent to which other percent reported prescription drug misuse in the past 6 months and, of those that reported past 6-month drug substance use increases the risk of prescription drug misuse, 91 percent also reported illicit drug use misuse. EAP providers should assess those seeking (compared to 68 percent of those who did not report services about all substance use—illicit drugs, prescription drug misuse in the past 6 months). The prescription drugs (medical and non-medical use), over- drug used most often in combination with prescription the-counter medications, and alcohol—as all these drug misuse was marijuana. Of those that misused substances, particularly if used in combination, can prescription drugs in the past 6 months, 59 percent impact work performance and safety. combined that use with marijuana (which comprised nearly 15 percent of the full sample).6 • As the dangers of opioid prescription drug misuse have These data indicate that prescription drug misuse is gained national attention, numerous regulatory initiatives and recommended changes in prescribing often found in combination with illicit drug use and the have led to stricter controls on opioid dispensing. While misuse of alcohol. When conducting behavioral health these efforts have been credited with reductions in screening, it is important that EAP providers ask clients opioid overdose deaths, there have been reports of about their full range of substance use, including medical shifts among some users to heroin.1,2 and non-medical use of prescription drugs. • According to the National Survey on Drug Use and References Health, approximately 404,000 people had misused prescription pain relievers and had used heroin in 2019; 1 Volkow, N. D. (2014). Prescription opioid and heroin abuse. Witness appearing before about 341,000 people had used heroin in 2019 but had the House Committee on Energy and Commerce Subcommittee on Oversight and not misused prescription pain relievers.3 Investigations. Washington, DC: Department of Health and Human Services, National Institutes of Health. • Analysis of a nationally representative U.S. sample 2 Cicero, T. J., & Ellis, M. S. (2015). Abuse-Deterrent Formulations and the prescription found that the odds of reporting past year non-medical opioid abuse epidemic in the United States: Lessons learned from OxyContin. JAMA Psychiatry, 72(5), 424–430. use of prescription drugs was 18 times higher among 3 Substance Abuse and Mental Health Services Administration. (2020). Key substance individuals with an alcohol use disorder compared to use and mental health indicators in the United States: Results from the 2019 those who did not drink alcohol.4 Adults ages 18 to 24 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, also had higher rates of binge drinking, alcohol use NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved disorders, and misuse of prescription drugs than those from https://www.samhsa.gov/data/ 25 and older. 4 McCabe, S. E., Cranford, J. A., Boyd, C. J. (2006). The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: Prevalence of co- • Research that looked at problem use of prescription occurrence in a national sample. Drug and Alcohol Dependence 84(3), 281–288. drugs (defined as heavy non-medical use or non- 5 Simoni-Wastila, L., & Strickler, G. (2004). Risk factors associated with problem use of medical use that met the criteria for a substance use prescription drugs. The American Journal of Public Health, 94, 266–268. disorder) found that problem non-medical tranquilizer 6 Kelly, B. C., Wells, B. E., Pawson, M., LeClair, A., & Parsons, J. T. (2014). use was associated with daily drinking.5 Combinations of prescription drug misuse and illicit drugs among young adults. Addictive Behaviors, 39(5), 941–944. 2 Workplace Awareness and Prevention Employee Assistance Program (EAP) professionals can play a critical role in promoting awareness of the problem of non-medical prescription use. In addition to providing educational and counseling services, EAP providers may also become involved in other workplace practices designed to prevent prescription drug misuse. Employees who engage in prescription drug misuse may Workplace Awareness exhibit the following behaviors: Workers may use prescription drugs to get high or to • Lack of attention or focus self-treat a medical condition with medication prescribed for someone else or previously prescribed to them for a • Poor decision-making different problem. Especially with pain relievers, they • Decreasing work quality also may take a larger dose than prescribed in hopes of increasing the therapeutic effect. Collectively, these • Poor judgment drug-taking behaviors are referred to as prescription • Unusual carelessness drug misuse. These behaviors put workers at risk for • Unsteady gait potentially fatal adverse drug reactions. They also can create workplace safety hazards. An employer may think • Excessive mood swings their employees do not have prescription drug misuse • Drowsiness problems; however, these problems often are referred to • Appearance of being high, unusually energetic or as a “hidden epidemic.” The sheer numbers of revved up, or sedated prescription medication users in all classes of U.S. society pose substantial risks. While prescription pain • Increased absenteeism, including unexplained absences or vague excuses for needing time off relievers are the leading medications that are misused, medications for anxiety, sleep disorders, depression, While none of these behaviors are a definitive indicator and attention-deficit/hyperactivity disorder (ADHD) also of prescription drug misuse, such behaviors may warrant are commonly misused. referral to the EAP. EAPs can play a critical role in the prevention of prescription drug misuse in the workplace The non-medical use of prescription drugs among and should be ready to assess the potential for problems employees can have significant negative impacts on the with prescription drugs, along with other behavioral employee, co-workers, and the workplace. The total health conditions. Understanding how those seeking economic burden of prescription opioid misuse alone in help from the EAP use prescription medication (whether the United States is $78.5 billion per year, including the medically or non-medically and/or in combination with costs of health care, lost productivity, addiction other substances) is vital information for EAP providers. treatment, and criminal justice involvement. It is estimated that prescription opioid misuse increases Preventing Prescription Drug Misuse health care and substance treatment costs by $29.4 billion, increases criminal justice costs by $7.8 billion, EAPs are ideally positioned to provide educational and reduces productivity among those who do not die of materials, training, and other resources related to overdose by $20.8 billion (in 2015).1 That does not take substance misuse prevention—including the non- into consideration the non-medical use of other types of medical use of prescription drugs. EAP professionals prescription drugs.2 can work with management to educate them about 3 recognizing and responding to substance misuse issues, recommendations. Counseling professionals affiliated including prescription drugs, so problems can be with the EAP will typically make an assessment, addressed in uniform, effective, and business-sensitive recommend treatment options, and develop a treatment ways. EAPs also provide behavior risk management, plan that stipulates return-to-work conditions. A well- prevention, and early identification and intervention defined and managed treatment plan that stipulates the services for those at risk for problems such as recovery and return-to-work criteria facilitates successful prescription drug misuse. EAPs can deliver prevention transition back to work. (See Return-to-Work fact sheet services designed to educate the entire workforce, as for more information.) well as direct prevention messages to high-risk Understanding the complexities of treating prescription individuals, thereby encouraging them to seek help. drug misuse and reflecting these considerations in drug- free workplace policies is a continuous challenge for What Are Types of Risk Management Activities to organizations and important for EAP providers to Address Prescription Drug Misuse? understand. One key consideration is the need to EAPs can conduct “brown bag” lunch meetings that accommodate the potential for ongoing medication use discuss the non-medical use of prescription drugs and for a recovering employee. Employees who have risk factors. This may encourage employees who are at returned to work following a positive test are generally risk, or whose family members may be at risk, to seek restricted from taking any potentially addicting early confidential counseling. EAPs can promote medication as part of their Return-to-Work Agreement. prescription drug “take-back” programs, post maps of Such drugs would most likely be detected on monitoring their locations, and provide information on how to drug tests and result in a violation of the Return-to-Work destroy unused medications. Resources, such as the Agreement. However, even successfully rehabilitated fact sheets included in this toolkit, can be distributed to employees may experience medical conditions or employees. EAP providers can create partnerships with injuries requiring the limited use of such medications. A supervisory staff to create re-occurring trainings as procedure for the pre-approval and safe use of these appropriate about the signs of prescription drug misuse medications on a case-by-case basis needs to be and the procedures they should follow within the context established for monitored employees. The EAP can help of their workplace policies if they suspect such use. design this procedure. EAP involvement in Recovery and Return-to-Work Modifying Drug-Free Workplace In addition to providing organizational resources and prevention interventions, EAP providers may also be Programs (DFWP) to Address Non- called on to manage the recovery and return-to-work Medical Use of Prescription Drugs process for employees who test positive for misused prescription drugs. In some cases, to successfully return Employers are responsible for protecting the safety of to work, and often as a condition of employment their employees. This responsibility includes developing stipulated in a drug-free workplace policy, employees and enforcing a DFWP. Contractors or grantees who who test positive for prescription drug misuse require the must comply with the Drug-Free Workplace Act of 1988 completion of a substance use treatment plan managed should pay special attention to elements required by the by an EAP or treatment professional, and random or Act. Requirements vary, based on whether the regular drug testing while in treatment (even if the contractor or grantee files as an individual or an employer does not have a broader prescription drug organization. In the future, employer drug testing testing program). Successfully returning to work is often requirements may be extended to detect certain the goal for both the company and the employee. prescription drug use that could impair employees from However, in some circumstances this process is highly safely performing their job duties. regulated. For example, if an employee works in a EAP professionals can play a critical role as workplaces safety-sensitive position, the employer must comply with consider modifying their DFWPs and policies to address several mandatory regulations before the employee prescription drugs. Below are the steps needed to returns to work, including ensuring that the employee update DFWPs to address prescription drugs and the has been evaluated by a substance use counselor and has successfully complied with the counselor’s 4 role that EAPs can play. For more information, go to • If applicable, the conditions that need to be met before https://www.samhsa.gov/workplace/workplace- the employee can return to work. programs. EAPs can participate in these discussions and help incorporate language to facilitate the identification, Step 1: Define the employee’s role in making the evaluation, treatment, and possible provisions to return- workplace safe. Sometimes employees in the to-work for employees who engage in prescription drug transportation, nuclear, construction, moving, mining, misuse. and other high-risk industries are prescribed pain relievers and other medications carrying warning labels. Step 4: Obtain legal advice. It is advisable for an If the warning label states, “Avoid driving or operating attorney experienced in DFWP issues to review the heavy machinery,” the medication may make a person revised DFWP policy before it is finalized. drowsy, dizzy, and/or lightheaded and may slow motor skills and reaction time. A DFWP should state what Step 5: Train supervisory staff and educate employees must do if they are prescribed medications employees. Conduct regular formal training to educate that carry this warning label. Employees in safety- supervisory staff about the signs of prescription drug sensitive positions should be responsible for discussing misuse and the procedures to follow for an employee their job duties and requirements with their medical care that a supervisor suspects has a prescription drug providers to avoid on-the-job impairment. misuse problem. Again, EAP professionals can play a role in training employees and supervisors as needed. Such discussions, documented in the medical record, are important to lessen safety risks. The DFWP also Step 6: Review service coverage for behavioral should spell out what steps will be taken if the employee health and/or EAP needs. The behavioral health is suspected of using any of these medications without a portions of health insurance and EAP contracts should prescription, in larger doses than prescribed, or more be evaluated to ensure that employees are covered for frequently than prescribed. Those in designated drug- issues related to prescription drug misuse. EAPs should tested positions should have updated information provide counseling services related to some co- regarding appropriate use of prescription drugs and occurring behavioral health and substance use issues. consequences for non-medical use. Prescription drug misuse should be included in these services and employees should be made aware of the Step 2: Decide if the company should add counseling services that the EAP can provide. EAPs are prescription drug testing to traditional illicit drug expected to assess employees’ prescription drug use— testing. This would involve organizational both medical and non-medical—to determine if the use representatives responsible for the drug testing program of prescription drugs contribute to workplace and protocols to ensure that any policy changes comply performance issues. with applicable local, state, and federal laws. Prescription Drug Monitoring Step 3: Incorporate language that spells out new Programs provisions of the DFWP that deal with prescription drug misuse. Make sure the policy details the complete EAP professionals may want to familiarize themselves course of action the employer will follow regarding non- with Prescription Drug Monitoring Programs (PDMPs), medical use of prescription drugs. Each employer must as they can be a cost-saving tool for employers and help develop their own policies regarding how suspected reduce the diversion of prescription medications for prescription drug misuse will be identified, evaluated, unintended purposes. PDMPs are housed in different and treated; the conditions for continued employment; state agencies that may include regulatory boards and work and leave options; and what medical certifications health departments, as well as law enforcement, are required. They must ensure the prescription drug consumer protection, and substance misuse agencies. use policy is clear, concise, and thorough. List PDMPs collect, monitor, and analyze electronically procedures or corrective actions the employer will follow: transmitted dispensing data submitted by pharmacies • For an employee suspected of prescription drug and, in some cases, dispensing practitioners. misuse; PDMPs produce a patient history and activity report for • For an employee with confirmed non-medical use; and each patient. These reports provide the health care 5 practitioner with a list of all controlled substance What Are Employers Allowed to Ask? prescription drugs prescribed to the patient, the name of the prescriber issuing each prescription, and the The Americans with Disabilities Act (ADA) protects the pharmacy where each prescription was filled. EAPs rights of job applicants and employees to be assessed themselves cannot access patient medical information on merit alone, while protecting the rights of employers from PDMPs. Generally, PDMPs distribute data to to ensure that individuals in the workplace can efficiently authorized medical professionals upon request; in some perform the essential functions of their jobs.6 The ADA states, PDMPs distribute data proactively. The patient applies to all employees, not just those with disabilities. activity report assists the physician in determining if a Medical information such as the non-medical use of patient altered the quantity of drugs prescribed or forged prescription drugs is protected under the ADA, so the physician’s name on prescriptions. The report also employers must be knowledgeable about ADA flags doctor shopping that yields multiple doses of a regulations before making any inquiries of their controlled substance. Information about each state’s employees or potential new hires. It is important that PDMP may be found at EAP providers understand what the employer can and http://www.pdmpassist.org/content/state-profiles. cannot ask at different stages of the hiring/employment process. So, why should EAPs be aware of PDMPs? PDMPs can save employers money and reduce non-medical use of Pre-Employment Inquiries prescription drugs. PDMPs reduce unnecessary and According to the ADA, employers cannot ask potential costly prescriptions for pain relievers and other addictive new hires: and controlled medications. They also can reduce the physician visits and diagnostic tests required to get • Questions about their prescription drug history before those prescriptions. PDMPs can help doctors identify they offer a job to the applicant. employees who may need a referral to treatment and Employers can ask potential new hires: identify those employees who might be undertreated and subsequently visit emergency departments to get relief • If they can perform all the job duties stated in the job description. via pain medication. PDMPs increase employee readiness and productivity by reducing misuse and » The applicant is required by law to notify the allowing patients to get adequate treatment. PDMPs employer of any prescribed drugs they may be can also provide large cost savings in workers’ taking that have side effects which can affect their compensation. The use of opioids increases the job duties. For many jobs, that includes drugs where labels say, “may cause drowsiness” or likelihood of long-term disability claims. Receiving more suggest caution when using heavy machinery than one week’s supply of opioids soon after an injury (which includes driving). doubles the risk of a worker’s disability a year later.3 After Job Offer; Before Employment Begins EAPs can talk with management or health plan Once a potential new hire completes the interview administrators to request that doctors included in the process and is offered a job, an employer can ask the company’s health plan use PDMPs. States with PDMPs employee: save on health care benefits through reductions in (1) admissions for inpatient and outpatient addiction • Health-related questions, including questions about the treatment, (2) prescription drug overdoses and use of prescribed drugs. associated health problems, and (3) prescription drug » This can only be done if all employees at the same costs associated with employer-funded purchases of job status are required to answer the same drugs diverted to abuse.4 One study estimated that using questions. These questions can be asked even if PDMPs nationwide could reduce health care costs by they do not relate to the job’s function. $113 million.5 6

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.